Oncternal Therapeutics shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Oncternal Therapeutics shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Oncternal Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Oncternal Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Oncternal Therapeutics by Charles Schwab Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $17k | 32k | 0.54 |
| 2023-09-30 | $9.8k | 32k | 0.30 |
| 2023-06-30 | $11k | 32k | 0.35 |
| 2023-03-31 | $25k | 32k | 0.79 |
| 2022-12-31 | $32k | 32k | 1.00 |
| 2022-09-30 | $29k | 32k | 0.90 |
| 2022-06-30 | $36k | 32k | 1.12 |
| 2022-03-31 | $131k | 94k | 1.40 |
| 2021-12-31 | $249k | 110k | 2.27 |
| 2021-09-30 | $458k | 110k | 4.18 |
| 2021-06-30 | $521k | 110k | 4.75 |
| 2021-03-31 | $132k | 16k | 8.33 |
More positions owned by Charles Schwab Investment Management
Home Depot (HD)
View all positions for Charles Schwab Investment Management